Income Statement Dhanuka Agritech Limited

Equities

507717

INE435G01025

Agricultural Chemicals

Market Closed - Bombay S.E. Other stock markets 10:00:46 06/03/2026 GMT			5-day change	1st Jan Change
986.25 ^INR	-0.58%		-2.94%	-16.45%

02-05	Dhanuka Agritech Limited, Q3 2026 Earnings Call, Feb 05, 2026
02-05	Dhanuka Agritech Limited Announces Board and Board Committee Changes	CI

642bfa3e50802bff.71LEHKOtDNg_UzCTioLcUCUXtNBFMd_Y4s9d9zRVoEw.miGIMZb3SotQIVL30-WoIGcu7oIcZbKftJVvnnIezRyAIKVb-cxKrlRgAA

Published financial data: DHANUKA AGRITECH LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	13.87B	14.78B	17B	17.59B	20.35B
Other Revenues, Total	-	-	-	-	-
Total Revenues	13.87B	14.78B	17B	17.59B	20.35B
Cost of Goods Sold, Total	8.63B	9.39B	11.15B	10.72B	12.19B
Gross Profit	5.24B	5.39B	5.85B	6.86B	8.16B
Selling General & Admin Expenses, Total	1.31B	1.35B	1.41B	1.74B	1.92B
Depreciation & Amortization - (IS)	152M	163M	176M	406M	555M
Other Operating Expenses	1.24B	1.4B	1.59B	1.84B	2.07B
Other Operating Expenses, Total	2.7B	2.91B	3.17B	3.99B	4.54B
Operating Income	2.54B	2.47B	2.67B	2.87B	3.62B
Interest Expense, Total	-26.94M	-32.03M	-31.18M	-30.87M	-51.12M
Interest And Investment Income	157M	141M	180M	196M	204M
Net Interest Expenses	130M	109M	149M	166M	153M
Currency Exchange Gains (Loss)	25.24M	-	-62.3M	-5.5M	-9.59M
Other Non Operating Income (Expenses)	4.85M	55.95M	7.94M	54.89M	75.03M
EBT, Excl. Unusual Items	2.7B	2.64B	2.77B	3.09B	3.84B
Gain (Loss) On Sale Of Investments	147M	131M	44.77M	88.21M	43.47M
Gain (Loss) On Sale Of Assets	2.28M	6.24M	215M	8.94M	37.8M
Asset Writedown	-	-1.95M	-1.33M	-68K	-
Other Unusual Items	1.14M	1.82M	222K	1.2M	316K
EBT, Incl. Unusual Items	2.85B	2.78B	3.03B	3.19B	3.92B
Income Tax Expense	744M	687M	692M	797M	952M
Earnings From Continuing Operations	2.11B	2.09B	2.34B	2.39B	2.97B
Net Income to Company	2.11B	2.09B	2.34B	2.39B	2.97B
Net Income - (IS)	2.11B	2.09B	2.34B	2.39B	2.97B
Net Income to Common Incl Extra Items	2.11B	2.09B	2.34B	2.39B	2.97B
Net Income to Common Excl. Extra Items	2.11B	2.09B	2.34B	2.39B	2.97B
Per Share Items
Net EPS - Basic	44.61	44.85	50.35	52.46	65.55
Basic EPS - Continuing Operations	44.61	44.85	50.35	52.46	65.55
Basic Weighted Average Shares Outstanding	47.2M	46.58M	46.38M	45.58M	45.3M
Net EPS - Diluted	44.61	44.85	50.35	52.46	65.55
Diluted EPS - Continuing Operations	44.61	44.85	50.35	52.46	65.55
Diluted Weighted Average Shares Outstanding	47.2M	46.58M	46.38M	45.58M	45.3M
Normalized Basic EPS	35.75	35.41	37.32	42.36	52.98
Normalized Diluted EPS	35.75	35.41	37.32	42.36	52.98
Dividend Per Share	2	14	2	14	2
Payout Ratio	-	22.3	11.97	19.06	9.21
Supplemental Items
EBITDA	2.64B	2.58B	2.79B	3.22B	4.07B
EBITA	2.54B	2.47B	2.67B	2.87B	3.62B
EBIT	2.54B	2.47B	2.67B	2.87B	3.62B
EBITDAR	2.66B	2.58B	2.8B	3.22B	4.08B
Total Revenues (As Reported)	14.21B	15.11B	17.45B	17.94B	20.71B
Effective Tax Rate - (Ratio)	26.1	24.75	22.87	24.99	24.27
Total Current Taxes	714M	714M	724M	769M	955M
Total Deferred Taxes	29.56M	-27.33M	-31.72M	27.24M	-2.85M
Normalized Net Income	1.69B	1.65B	1.73B	1.93B	2.4B
Interest on Long-Term Debt	20.17M	30.35M	28.3M	25.59M	27.44M
Non-Cash Pension Expense	2.78M	223K	95K	1.44M	977K
Supplemental Operating Expense Items
Advertising Expense	107M	141M	138M	189M	192M
Selling and Marketing Expenses	107M	141M	138M	189M	192M
Research And Development Expense From Footnotes	27.15M	43.39M	28.98M	28.18M	42.41M
Net Rental Expense, Total	24.16M	5.85M	7.04M	2.66M	4.12M
Imputed Operating Lease Interest Expense	16.98M	3.74M	5.38M	2.17M	3.33M
Imputed Operating Lease Depreciation	7.17M	2.11M	1.66M	488K	790K

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	6.14M	14.85M	34.83M	5.09M	5.7M
Short Term Investments	-	50M	958M	150M	-
Trading Asset Securities, Total	1.88B	1.91B	-	568M	1.24B
Total Cash And Short Term Investments	1.88B	1.98B	993M	723M	1.24B
Accounts Receivable, Total	2.43B	2.82B	3.39B	3.47B	4.59B
Other Receivables	485M	966M	976M	1.28B	713M
Notes Receivable	402M	7.27M	4.71M	258M	140M
Total Receivables	3.31B	3.8B	4.37B	5.01B	5.44B
Inventory	2.96B	3.47B	3.45B	4.18B	3.99B
Prepaid Expenses	2.96M	20.95M	24.37M	27.21M	21.87M
Other Current Assets, Total	428M	280M	123M	319M	791M
Total Current Assets	8.58B	9.55B	8.96B	10.26B	11.49B
Gross Property Plant And Equipment	2.34B	2.78B	4.04B	4.69B	5.02B
Accumulated Depreciation	-615M	-728M	-873M	-1.19B	-1.66B
Net Property Plant And Equipment	1.73B	2.05B	3.17B	3.49B	3.36B
Long-term Investments	903M	1.4B	1.59B	1.68B	1.07B
Other Intangibles, Total	19.29M	15.46M	11.95M	8.99M	1.61B
Loans Receivable Long-Term	40.02M	1.07M	4.06M	1.79M	1.91M
Other Long-Term Assets, Total	39.16M	106M	320M	350M	470M
Total Assets	11.31B	13.12B	14.05B	15.79B	18B
Liabilities
Accounts Payable, Total	1.02B	1.72B	1.72B	1.48B	1.32B
Accrued Expenses, Total	234M	154M	194M	216M	279M
Short-term Borrowings	83.58M	9.62M	38.08M	4.68M	422M
Current Portion of Leases	37.79M	34.91M	40.46M	40.53M	53M
Current Income Taxes Payable	58.13M	113M	104M	83.19M	95.81M
Other Current Liabilities	1.33B	1.01B	887M	957M	1.32B
Total Current Liabilities	2.76B	3.04B	2.98B	2.78B	3.49B
Long-Term Leases	363M	274M	257M	225M	268M
Pension & Other Post Retirement Benefits	3.36M	1.32M	19.46M	13.58M	10.54M
Deferred Tax Liability Non Current	82.95M	55.62M	23.9M	51.14M	48.29M
Other Non Current Liabilities	141M	144M	161M	162M	162M
Total Liabilities	3.35B	3.52B	3.44B	3.23B	3.97B
Common Stock, Total	93.16M	93.16M	91.16M	91.16M	90.16M
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	7.85B	9.49B	10.5B	12.45B	13.92B
Comprehensive Income and Other	16.43M	16.43M	18.43M	18.43M	19.43M
Total Common Equity	7.96B	9.6B	10.61B	12.56B	14.03B
Total Equity	7.96B	9.6B	10.61B	12.56B	14.03B
Total Liabilities And Equity	11.31B	13.12B	14.05B	15.79B	18B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	46.58M	46.58M	45.58M	45.58M	45.08M
ECS Total Common Shares Outstanding	46.58M	46.58M	45.58M	45.58M	45.08M
Book Value / Share	170.94	206.19	232.85	275.54	311.17
Tangible Book Value	7.94B	9.59B	10.6B	12.55B	12.41B
Tangible Book Value Per Share	170.52	205.86	232.59	275.34	275.38
Total Debt	484M	318M	335M	270M	742M
Net Debt	-1.4B	-1.66B	-657M	-454M	-499M
Debt Equivalent of Unfunded Proj. Benefit Obligation	3.36M	1.32M	19.46M	13.58M	10.54M
Debt Equivalent Oper. Leases	193M	46.8M	56.33M	21.27M	32.93M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.05B	1.46B	1.38B	1.74B	1.75B
Inventories - Work In Process, Total	59.66M	80.6M	74.85M	115M	128M
Inventories - Finished Goods, Total	1.84B	1.93B	1.99B	2.31B	2.09B
Inventories - Others	5.52M	6.94M	7.77M	17.97M	18.94M
Land - (BS)	339M	348M	333M	332M	399M
Buildings, Total	919M	983M	1.04B	2.05B	2.28B
Machinery, Total	549M	578M	728M	1.65B	1.79B
Full Time Employees	941	969	1.04K	1.14K	1.11K
Accumulated Allowance for Doubtful Accounts (Supple)	46.37M	55.34M	68.37M	80.25M	95.91M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	2.11B	2.09B	2.34B	2.39B	2.97B
Depreciation & Amortization - CF	147M	159M	172M	402M	511M
Depreciation & Amortization, Total	147M	159M	172M	402M	511M
Amortization of Deferred Charges, Total - (CF)	4.39M	4.25M	4.17M	4.01M	43.93M
(Gain) Loss From Sale Of Asset	-2.28M	-6.24M	-215M	-8.94M	-37.8M
(Gain) Loss on Sale of Investments - (CF)	-147M	-131M	-44.77M	-88.21M	-43.47M
Asset Writedown & Restructuring Costs	-	1.95M	1.33M	68K	-
Provision and Write-off of Bad Debts	35.15M	23.64M	13.03M	16.84M	10.52M
Other Operating Activities, Total	-1.68M	-80.21M	-193M	-164M	-153M
Change In Accounts Receivable	-2.55M	-407M	-579M	-89.13M	-1.14B
Change In Inventories	-456M	-906M	21.18M	-728M	191M
Change In Accounts Payable	-41.75M	659M	8.85M	-257M	-90.17M
Change in Other Net Operating Assets	669M	-363M	-162M	-133M	364M
Cash from Operations	2.31B	1.04B	1.36B	1.34B	2.63B
Capital Expenditure	-126M	-598M	-1.24B	-893M	-1.94B
Sale of Property, Plant, and Equipment	3.62M	16.59M	243M	12.77M	48.45M
Investment in Marketable and Equity Securities, Total	-1.16B	-363M	870M	127M	123M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-140M	390M	7.15M	-245M	120M
Other Investing Activities, Total	156M	128M	148M	190M	221M
Cash from Investing	-1.27B	-426M	25.65M	-809M	-1.43B
Short Term Debt Issued, Total	3.74M	-	28.46M	-	417M
Total Debt Issued	3.74M	-	28.46M	-	417M
Short Term Debt Repaid, Total	-	-73.96M	-	-33.4M	-
Long-Term Debt Repaid, Total	-34.89M	-36.23M	-38.18M	-45.37M	-49.58M
Total Debt Repaid	-34.89M	-110M	-38.18M	-78.77M	-49.58M
Repurchase of Common Stock	-1.23B	-	-850M	-	-1B
Common Dividends Paid	-	-466M	-279M	-456M	-273M
Common & Preferred Stock Dividends Paid	-	-466M	-279M	-456M	-273M
Other Financing Activities, Total	-26.94M	-32.03M	-229M	-30.87M	-293M
Cash from Financing	-1.29B	-608M	-1.37B	-565M	-1.2B
Net Change in Cash	-246M	8.71M	19.98M	-29.74M	609K
Supplemental Items
Cash Interest Paid	26.94M	32.03M	31.18M	30.87M	51.12M
Cash Income Tax Paid (Refund)	610M	660M	733M	794M	947M
Levered Free Cash Flow	1.47B	581M	90.33M	-441M	411M
Unlevered Free Cash Flow	1.49B	601M	110M	-421M	443M
Change In Net Working Capital	121M	510M	496M	1.73B	435M
Net Debt Issued / Repaid	-31.15M	-110M	-9.72M	-78.77M	368M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	15.38	12.66	12.3	12.04	13.39
Return on Total Capital	20.28	16.84	16.02	15.11	16.4
Return On Equity %	28	23.78	23.1	20.64	22.34
Return on Common Equity	28	23.78	23.1	20.64	22.34
Margin Analysis
Gross Profit Margin %	37.78	36.45	34.39	39.03	40.1
SG&A Margin	9.47	9.15	8.28	9.92	9.42
EBITDA Margin %	19.02	17.44	16.42	18.32	20.01
EBITA Margin %	18.3	16.74	15.73	16.35	17.79
EBIT Margin %	18.3	16.74	15.73	16.35	17.79
Income From Continuing Operations Margin %	15.18	14.14	13.73	13.6	14.59
Net Income Margin %	15.18	14.14	13.73	13.6	14.59
Net Avail. For Common Margin %	15.18	14.14	13.73	13.6	14.59
Normalized Net Income Margin	12.16	11.16	10.18	10.98	11.79
Levered Free Cash Flow Margin	10.63	3.93	0.53	-2.51	2.02
Unlevered Free Cash Flow Margin	10.75	4.07	0.65	-2.4	2.18
Asset Turnover
Asset Turnover	1.34	1.21	1.25	1.18	1.2
Fixed Assets Turnover	9.52	7.82	6.51	5.28	5.94
Receivables Turnover (Average Receivables)	5.72	5.63	5.47	5.13	5.05
Inventory Turnover (Average Inventory)	3.17	2.92	3.22	2.81	2.99
Short Term Liquidity
Current Ratio	3.11	3.14	3.01	3.69	3.29
Quick Ratio	1.74	1.89	1.8	1.97	1.88
Operating Cash Flow to Current Liabilities	0.84	0.34	0.46	0.48	0.75
Days Sales Outstanding (Average Receivables)	63.8	64.85	66.71	71.37	72.27
Days Outstanding Inventory (Average Inventory)	115.29	124.9	113.26	130.22	122.25
Average Days Payable Outstanding	41.77	50.43	56.33	51.08	42.54
Cash Conversion Cycle (Average Days)	137.32	139.33	123.65	150.51	151.99
Long Term Solvency
Total Debt/Equity	6.08	3.31	3.16	2.15	5.29
Total Debt / Total Capital	5.73	3.21	3.06	2.1	5.03
LT Debt/Equity	4.56	2.85	2.42	1.79	1.91
Long-Term Debt / Total Capital	4.3	2.76	2.34	1.75	1.81
Total Liabilities / Total Assets	29.6	26.81	24.48	20.47	22.08
EBIT / Interest Expense	94.26	77.25	85.77	93.12	70.84
EBITDA / Interest Expense	99.74	82.2	91.29	106.13	80.83
(EBITDA - Capex) / Interest Expense	95.05	63.52	51.46	77.19	42.88
Total Debt / EBITDA	0.18	0.12	0.12	0.08	0.18
Net Debt / EBITDA	-0.52	-0.63	-0.23	-0.14	-0.12
Total Debt / (EBITDA - Capex)	0.19	0.16	0.21	0.11	0.34
Net Debt / (EBITDA - Capex)	-0.55	-0.81	-0.41	-0.19	-0.23
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	23.87	6.51	15.05	3.43	15.73
Gross Profit, 1 Yr. Growth %	28.35	2.77	8.55	17.37	18.9
EBITDA, 1 Yr. Growth %	56.9	-2.35	7.77	15.38	26.41
EBITA, 1 Yr. Growth %	61.04	-2.57	7.5	7.47	25.98
EBIT, 1 Yr. Growth %	61.04	-2.57	7.5	7.47	25.98
Earnings From Cont. Operations, 1 Yr. Growth %	48.96	-0.79	11.78	2.39	24.2
Net Income, 1 Yr. Growth %	48.96	-0.79	11.78	2.39	24.2
Normalized Net Income, 1 Yr. Growth %	55.52	-2.23	4.92	11.57	24.3
Diluted EPS Before Extra, 1 Yr. Growth %	50.16	0.53	12.27	4.19	24.96
Accounts Receivable, 1 Yr. Growth %	0.11	16.41	20.02	2.28	32.41
Inventory, 1 Yr. Growth %	18.27	17.49	-0.61	21.1	-4.58
Net Property, Plant and Equip., 1 Yr. Growth %	45.32	19.04	54.1	10.37	-3.81
Total Assets, 1 Yr. Growth %	21.33	16.02	7.1	12.37	13.99
Tangible Book Value, 1 Yr. Growth %	12.62	20.72	10.56	18.38	-1.08
Common Equity, 1 Yr. Growth %	12.52	20.63	10.5	18.33	11.69
Cash From Operations, 1 Yr. Growth %	42.56	-54.87	30.64	-1.3	95.34
Capital Expenditures, 1 Yr. Growth %	-8.04	374.13	107.58	-28.06	117.15
Levered Free Cash Flow, 1 Yr. Growth %	14.74	-60.57	-84.69	-587.78	-193.3
Unlevered Free Cash Flow, 1 Yr. Growth %	15.17	-59.68	-82	-483.66	-205.15
Dividend Per Share, 1 Yr. Growth %	-83.33	600	-85.71	600	-85.71
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.45	14.86	10.7	9.09	9.41
Gross Profit, 2 Yr. CAGR %	16.05	14.85	5.62	12.88	18.14
EBITDA, 2 Yr. CAGR %	34.57	23.78	2.86	11.51	20.77
EBITA, 2 Yr. CAGR %	37.76	25.26	2.63	7.49	16.36
EBIT, 2 Yr. CAGR %	37.76	25.26	2.63	7.49	16.36
Earnings From Cont. Operations, 2 Yr. CAGR %	36.76	21.57	5.31	6.98	12.77
Net Income, 2 Yr. CAGR %	36.76	21.57	5.31	6.98	12.77
Normalized Net Income, 2 Yr. CAGR %	35.29	23.31	1.28	8.19	17.76
Diluted EPS Before Extra, 2 Yr. CAGR %	39.21	22.87	6.24	8.15	14.1
Accounts Receivable, 2 Yr. CAGR %	5.34	7.95	18.2	10.79	16.37
Inventory, 2 Yr. CAGR %	19.53	17.88	8.06	9.71	7.5
Net Property, Plant and Equip., 2 Yr. CAGR %	22.34	31.52	35.44	30.42	3.04
Total Assets, 2 Yr. CAGR %	16.36	18.64	11.47	9.7	13.18
Tangible Book Value, 2 Yr. CAGR %	11.43	16.6	15.53	14.4	8.21
Common Equity, 2 Yr. CAGR %	11.34	16.5	15.45	14.35	14.97
Cash From Operations, 2 Yr. CAGR %	316.86	-19.79	-23.22	13.56	38.86
Capital Expenditures, 2 Yr. CAGR %	44.11	108.81	213.72	22.2	24.99
Levered Free Cash Flow, 2 Yr. CAGR %	450.88	-32.74	-75.25	-13.58	113.33
Unlevered Free Cash Flow, 2 Yr. CAGR %	488.86	-31.85	-72.86	-16.89	100.86
Dividend Per Share, 2 Yr. CAGR %	82.57	8.01	0	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	12.96	13.68	14.93	8.22	11.26
Gross Profit, 3 Yr. CAGR %	9.39	11.45	12.71	9.4	14.85
EBITDA, 3 Yr. CAGR %	16.79	20.93	18.4	6.88	16.27
EBITA, 3 Yr. CAGR %	18.69	22.74	19.26	4.22	13.33
EBIT, 3 Yr. CAGR %	18.69	22.74	19.26	4.22	13.33
Earnings From Cont. Operations, 3 Yr. CAGR %	18.61	22.88	18.21	4.33	12.44
Net Income, 3 Yr. CAGR %	18.61	22.88	18.21	4.33	12.44
Normalized Net Income, 3 Yr. CAGR %	18.3	21.41	16.85	4.6	13.31
Diluted EPS Before Extra, 3 Yr. CAGR %	20.17	24.9	19.23	5.55	13.49
Accounts Receivable, 3 Yr. CAGR %	5.28	8.91	11.83	12.64	17.58
Inventory, 3 Yr. CAGR %	12.97	18.85	11.36	12.24	4.72
Net Property, Plant and Equip., 3 Yr. CAGR %	10.47	21.23	38.66	26.51	17.83
Total Assets, 3 Yr. CAGR %	11.19	16.25	14.66	11.77	11.11
Tangible Book Value, 3 Yr. CAGR %	8.01	14.45	14.55	16.47	8.99
Common Equity, 3 Yr. CAGR %	7.92	14.36	14.47	16.41	13.46
Cash From Operations, 3 Yr. CAGR %	18.83	98.67	-5.63	-16.51	36.06
Capital Expenditures, 3 Yr. CAGR %	24.84	114.34	108.4	92.03	48.02
Levered Free Cash Flow, 3 Yr. CAGR %	8.1	128.72	-58.73	-33.14	-11.34
Unlevered Free Cash Flow, 3 Yr. CAGR %	8.35	140.91	-56.06	-34.38	-10.11
Dividend Per Share, 3 Yr. CAGR %	-28.62	185.75	-44.97	91.29	-47.72
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.85	10.84	12.05	11.82	12.69
Gross Profit, 5 Yr. CAGR %	10.16	6.97	7.87	12.02	14.85
EBITDA, 5 Yr. CAGR %	13.48	8.73	11	17.19	19.34
EBITA, 5 Yr. CAGR %	13.54	9.8	11.99	16.53	18.09
EBIT, 5 Yr. CAGR %	13.54	9.8	11.99	16.53	18.09
Earnings From Cont. Operations, 5 Yr. CAGR %	14.43	11.38	13.1	16.26	16.01
Net Income, 5 Yr. CAGR %	14.43	11.38	13.1	16.26	16.01
Normalized Net Income, 5 Yr. CAGR %	13.85	9.5	11.17	15.94	17.21
Diluted EPS Before Extra, 5 Yr. CAGR %	15.77	12.97	14.39	17.91	17.15
Accounts Receivable, 5 Yr. CAGR %	5.49	8.97	10.27	9.66	13.63
Inventory, 5 Yr. CAGR %	11.36	5.59	10.98	15.1	9.8
Net Property, Plant and Equip., 5 Yr. CAGR %	5.61	8.69	19.85	24.82	23.13
Total Assets, 5 Yr. CAGR %	11.49	12.92	11.3	13.58	14.07
Tangible Book Value, 5 Yr. CAGR %	10.67	13.07	10.96	14.43	11.97
Common Equity, 5 Yr. CAGR %	10.63	12.98	10.88	14.35	14.67
Cash From Operations, 5 Yr. CAGR %	10.59	10.56	-0.21	58.84	10.14
Capital Expenditures, 5 Yr. CAGR %	-16.77	24.58	80.48	71.2	69.86
Levered Free Cash Flow, 5 Yr. CAGR %	22.41	38.82	-40.06	55.42	-20.38
Unlevered Free Cash Flow, 5 Yr. CAGR %	22.37	38.29	-37.73	57.84	-19.3
Dividend Per Share, 5 Yr. CAGR %	-21	87.76	-18.32	87.76	-30.12